FDA clears Teva asthma med (TEVA) – Seeking Alpha (registration)


Nasdaq

FDA clears Teva asthma med (TEVA)
Seeking Alpha (registration)
The FDA approves Teva Pharmaceutical Industries' (NYSE:TEVA) ProAir RespiClick (albuterol sulfate) inhalation powder for the treatment or prevention of bronchospasm in patients at least 12 years old with reversible obstructive airway disease and for
Teva Announces FDA Approval of ProAir® RespiClickBusiness Wire (press release)
Teva Announces FDA Approval of ProAir(R) RespiClickFinances.com

all 5 news articles »

View full post on asthma – Google News

FDA Panel Recommends Asthma Treatment Approval for Adults Only – Pharmacy Times (registration)


Uncover California

FDA Panel Recommends Asthma Treatment Approval for Adults Only
Pharmacy Times (registration)
"We recognize the advisory committee's thoroughness in reviewing the data related to Breo Ellipta for asthma,” said Darrell Baker, senior vice president and head of GSK's Global Respiratory Franchise, in a press release. “We will continue to work
GSK And Theravance: Implications Of The Advisory Panel DecisionSeeking Alpha (registration)
Breo Ellipta receives Mixed Views from FDA PanelUncover California

all 4 news articles »

View full post on asthma – Google News

OTC Asthma Products Labeled Homeopathic Pose Potential Health Risks – Pharmacy Times (registration)

OTC Asthma Products Labeled Homeopathic Pose Potential Health Risks
Pharmacy Times (registration)
“Consumers with asthma can take an active role in managing their condition by making certain they have appropriate treatments on hand in the event they experience an asthma attack or a worsening of asthma symptoms, and by consulting with a health care …

View full post on asthma – Google News

Investors appear to wake up to potential of BioTime’s Asthma iPhone app (BTX) – Seeking Alpha (registration)

Investors appear to wake up to potential of BioTime's Asthma iPhone app (BTX)
Seeking Alpha (registration)
Thinly-traded small cap BioTime (BTX +16.1%) jumps on a 4x surge in volume in (what appears to be) belated response to the March 9 announcement by Mount Sinai's Icahn School of Medicine that it is launching a large-scale research study of asthma using …

View full post on asthma – Google News

Investigational Asthma Treatment Cuts Exacerbation Rates in Half – Pharmacy Times (registration)

Investigational Asthma Treatment Cuts Exacerbation Rates in Half
Pharmacy Times (registration)
The study compared the anti-interleukin-5 (IL-5) monoclonal antibody, reslizumab, with placebo in 953 patients with both asthma and elevated blood eosinophil levels. The research team found that patients treated with reslizumab in the first study

View full post on asthma – Google News